exosom
small
nm
membran
vesicl
releas
hematopoiet
nonhematopoiet
cell
function
promot
intercellular
commun
gener
fusion
multivesicular
bodi
plasma
membran
releas
interlumin
vesicl
previou
studi
laboratori
demonstr
macrophag
infect
mycobacterium
releas
exosom
promot
activ
innat
acquir
immun
respons
howev
compon
present
exosom
induc
host
respons
defin
studi
use
lcmsm
identifi
mycobacteri
protein
present
exosom
releas
tuberculosisinfect
cell
mani
protein
character
highli
immunogen
sinc
mycobacteri
protein
identifi
activ
secret
hypothes
macrophag
treat
tuberculosi
cultur
filtrat
protein
cfp
would
releas
exosom
contain
mycobacteri
protein
found
tuberculosi
protein
exosom
releas
cfptreat
cell
major
also
present
exosom
isol
tuberculosisinfect
cell
exosom
cfptreat
cell
could
promot
macrophag
dendrit
cell
activ
well
activ
cell
vivo
result
suggest
exosom
contain
tuberculosi
antigen
may
altern
approach
develop
tuberculosi
vaccin
releas
bioactiv
vesicl
one
cell
interact
other
expand
mechan
intercellular
commun
exosom
one
type
bioactiv
vesicl
receiv
consider
attent
deriv
releas
intralumin
vesicl
upon
fusion
multivesicular
bodi
mvb
plasma
membran
therefor
contain
constitu
present
endocyt
network
moreov
exosom
function
divers
known
releas
numer
cell
type
includ
cell
hematopoiet
nonhematopoiet
origin
exosom
releas
origin
observ
matur
reticulocyt
appear
function
elimin
nonessenti
protein
matur
red
blood
cell
later
studi
demonstr
exosom
deriv
b
cell
antigenpres
cell
enrich
mhc
class
ii
well
costimulatori
molecul
like
could
present
antigen
sensit
cell
recent
studi
shown
exosom
carri
tumor
antigen
promot
antigenspecif
tcell
activ
tumor
reject
vivo
better
understand
exosom
function
immunoelectron
microscopi
western
blot
mass
spectrometri
use
defin
exosom
composit
studi
identifi
common
well
celltyp
specif
protein
moreov
composit
excret
exosom
chang
cell
origin
expos
differ
environment
condit
foreign
materi
found
exosom
releas
mycobacteriuminfect
macrophag
carri
mycobacteri
antigen
kda
lipoprotein
lipoarabinomannan
exosom
releas
mycobacterialinfect
macrophag
induc
proinflammatori
respons
macrophag
interestingli
exosom
isol
bovi
bcg
infect
macrophag
administ
intranas
mice
stimul
antigenspecif
cell
suggest
exosom
contain
number
mycobacteri
antigen
howev
mycobacteri
protein
present
isol
exosom
could
promot
tcell
activ
defin
studi
therefor
address
question
establish
first
extens
proteom
analysi
exosom
isol
tuberculosi
macrophag
analysi
identifi
mycobacteri
protein
includ
wellknown
antigen
protein
complex
also
found
cell
incub
mycobactrium
tuberculosi
mtb
cultur
filtrat
protein
cfp
releas
exosom
contain
number
highli
antigen
mtb
protein
moreov
exosom
could
stimul
macrophag
dendrit
cell
dc
activ
vitro
activ
cell
vivo
suggest
possibl
use
exosom
tb
vaccin
mtb
stock
gener
describ
appropri
concentr
mycobacteria
suspend
dmem
gibco
contain
normal
hors
serum
sourc
complement
compon
follow
h
incub
mous
macrophag
cell
line
maintain
co
dmem
supplement
fb
life
technolog
mm
na
hepe
penicillin
mgml
streptomycin
biowhittak
walkersvil
md
infect
macrophag
complementopson
bcg
carri
h
seed
cell
infect
h
describ
cfp
treatment
cell
seed
tissu
cultur
flask
treat
cfp
mgml
ml
dmem
supplement
exosomefre
fc
h
cultur
supernat
harvest
exosom
purif
bone
marrowderiv
dendrit
cell
bmdc
harvest
bone
marrow
balbc
mice
describ
previous
matur
bmdc
harvest
store
evalu
secret
bmdc
follow
exosom
treatment
bmdc
thaw
seed
plate
cell
well
ml
exosomefre
cultur
media
h
treat
cfp
exosom
untreat
ut
exosom
differ
concentr
h
cellfre
cultur
supernat
harvest
quantif
elisa
accord
manufactur
instruct
endogen
woburn
exosom
isol
purifi
describ
previous
exosom
administ
mice
three
dose
wk
interv
via
intranas
rout
time
point
mice
lightli
anesthet
isofluran
ml
volum
contain
mg
exosom
cfptreat
untreat
macrophag
mg
cpgodn
invitrogen
adjuv
pb
administ
dropwis
extern
nare
mice
ml
per
nostril
use
micropipett
posit
control
bcg
administ
singl
dose
cfumous
ml
pb
via
intranas
rout
describ
neg
control
group
receiv
cpgodn
adjuv
pb
spleen
bcginfect
mice
isol
day
infect
isol
spleen
mediastin
lymph
node
mln
exosometr
ut
anim
mice
sacrif
wk
final
immun
spleen
mln
asept
remov
spleen
perfus
use
ml
syring
fit
needl
obtain
singl
cell
suspens
splenocyt
mln
cell
separ
singl
cell
use
pistol
ml
steril
dispovan
syring
splenocyt
mln
cell
suspens
centrifug
g
min
rbc
lyse
hypoton
shock
use
ml
ack
lysi
buffer
min
cell
wash
thrice
rpmi
remov
lyse
rbc
lysi
buffer
lung
lymphocyt
exosom
treat
ut
well
infect
mice
isol
describ
previous
minor
modif
pool
lung
homogen
ml
steril
complet
glass
homogen
incub
h
type
iv
collagenas
uml
dnase
uml
digest
lung
tissu
press
mm
nylon
mesh
centrifug
g
min
cell
pellet
resuspend
complet
media
cell
suspens
layer
histoplaqu
densiti
centrifug
carri
min
g
room
temperatur
lung
mononuclear
cell
obtain
interfac
wash
count
resuspend
concentr
cellsml
complet
media
tricolor
flow
cytometri
done
analysi
memori
phenotyp
two
week
final
immun
day
bcg
infect
lung
mln
spleen
cell
isol
exosomestr
ut
anim
cell
wash
fac
wash
buffer
incub
ice
panel
antibodi
concentr
mg
million
cell
ml
fac
buffer
min
cell
wash
fix
paraformaldehyd
analyz
flow
cytometri
analysi
done
acquisit
event
gate
cell
lymphocyterich
region
base
forwardangl
light
scatter
log
phycoerythrin
fluoresc
express
gate
lymphocyt
analyz
cell
stain
isotyp
control
antibodi
analyz
time
point
exosom
pellet
resuspend
fix
pb
contain
glutaraldehyd
load
onto
formarcarbonco
electron
microscopi
grid
sampl
contrast
uranyl
acet
visual
membran
view
hitachi
tem
microscop
hitachi
usa
mycobacteri
compon
exosom
detect
western
blot
briefli
mg
exosom
load
well
onto
sdspage
gel
electrophores
transfer
onto
pvdf
millipor
membran
probe
appropri
dilut
monoclon
antibodi
groe
katg
kda
lipoprotein
lpqh
glna
soda
mycobacteri
antigen
follow
incub
hrpconjug
secondari
antibodi
detect
use
enhanc
chemiluminesc
kit
roch
diagnost
usa
antibodi
mycobacteri
compon
obtain
colorado
state
univers
colorado
usa
tb
vaccin
test
research
materi
contract
nihniaid
spleen
asept
remov
cfp
treat
control
mice
wk
postimmun
singl
cell
suspens
splenocyt
gener
describ
splenocyt
suspens
centrifug
g
min
rbc
lyse
min
ack
lysi
buffer
cell
wash
thrice
rpmi
remov
lyse
rbc
ack
buffer
splenocyt
cfp
treat
control
mice
seed
tissu
cultur
plate
cellswel
ml
supplement
heatinactiv
fc
mm
hepe
mm
lglutamin
mm
sodium
pyruv
iuml
penicillin
mgml
streptomycin
presenc
absenc
cfp
exosom
ut
exosom
cfp
differ
concentr
h
phytohemagglutinin
pha
mgml
use
posit
control
cell
viabil
cellfre
cultur
supernat
harvest
h
ifng
tnfa
level
analyz
elisa
per
manufactur
instruct
use
elisa
kit
bioscienc
carboxi
fluoroscein
succinimidyl
ester
cfse
label
splenocyt
mln
lymphocyt
lung
lymphocyt
cfp
exosom
adjuv
ut
exosom
treat
mice
label
cfse
mm
cellswel
seed
tissu
cultur
plate
ml
supplement
heatinactiv
fc
mm
hepe
mm
lglutamin
mm
sodium
pyruv
iuml
penicillin
mgml
streptomycin
presenc
absenc
cfp
mgml
phytohemagglutinin
mgml
use
posit
control
cell
viabil
cell
incub
h
co
dilut
cfse
h
analyz
flow
cytometri
intracellular
ifng
lymphocyt
spleen
lung
mln
treat
cfp
mgml
total
h
final
h
presenc
mm
monensin
cell
first
stain
fix
paraformaldehyd
permeabil
permeabil
buffer
biolegend
stain
antiifngfitc
biolegend
accord
manufactur
instruct
label
cell
wash
fac
buffer
analyz
flow
cytometri
determin
optim
method
analysi
exosom
protein
multipl
method
use
includ
insolut
digest
ingel
fraction
prior
digest
summar
tabl
ingel
methodolog
gener
abund
highqual
spectra
reason
exosom
purifi
irradiatedmtbinfect
cfptreat
cell
process
via
protocol
total
mg
sampl
ad
break
buffer
final
volum
ml
break
buffer
compos
ml
pb
ph
gibco
mm
edta
ml
dnase
stock
mgml
ml
rnase
stock
mgml
lysi
exosom
achiev
sonic
ice
microtip
probe
use
five
round
puls
rest
result
lysat
denatur
guanidin
hydrochlorid
reduc
mm
dtt
alkyl
mm
iodoacetamid
overnight
microdialysi
mm
ammonium
bicarbon
sampl
digest
trypsin
trypsin
lysat
acn
overnight
digest
dri
resuspend
ltq
load
buffer
acn
formic
acid
h
digest
perform
deplastic
tube
reduc
plastic
polym
contamin
briefli
tube
deplastic
incub
ml
acn
tfa
h
room
temperatur
three
time
total
mg
sampl
separ
gradient
trisglycin
cm
cm
minigel
invitrogen
lane
fraction
ten
subsampl
subject
overnight
digest
mg
trypsin
digest
stop
total
volum
tfa
peptid
extract
gel
slice
use
two
round
ml
extract
solut
acn
formic
acid
min
supernat
dri
resuspend
ltq
load
buffer
acn
formic
acid
h
aliquot
ml
approxim
ngml
sampl
use
analysi
ms
peptid
purifi
concentr
use
onlin
enrich
column
agil
zorbax
mm
mm
column
agil
nanohplc
subsequ
chromatograph
separ
perform
reversephas
nanospray
column
zorbax
mm
mm
mm
column
sampl
elut
ltq
linear
ion
trap
thermo
scientif
use
flow
rate
nlmin
follow
gradient
profil
b
min
b
min
b
min
b
min
acn
formic
acid
b
acn
formic
acid
elong
method
optim
separ
complex
sampl
whole
cell
lysat
mass
spectra
collect
mz
rang
da
use
dynam
exclus
limit
two
msm
spectra
given
peptid
mass
exclus
durat
compound
list
result
spectra
gener
use
biowork
softwar
thermo
scientif
intens
threshold
scangroup
sampl
run
triplic
initi
inject
ion
collect
howev
due
abund
mous
exosom
protein
exclus
list
design
elimin
collect
top
abund
ion
allow
collect
fragment
less
abund
ion
would
otherwis
suppress
comparison
peptid
identifi
insolut
ingel
trypsin
digest
without
use
exclus
list
summar
tabl
although
mani
case
exclus
list
provid
identif
addit
peptid
rare
increas
number
protein
identif
therefor
subsequ
experi
use
exosom
purifi
irradiatedmtbinfect
cfptreat
cell
exclus
list
use
databas
search
tandem
mass
spectra
raw
file
extract
lcqdtaex
wwwmatrixsciencecom
antigen
dnak
tal
iodoacetamid
deriv
cyctein
acrylamid
adduct
cystein
specifi
variabl
modif
order
calcul
fals
discoveri
rate
fdr
data
set
raw
file
search
decoy
databas
decoy
databas
contain
revers
version
protein
includ
either
custom
databas
compos
mtb
fasta
file
sequest
well
concaten
revers
ipi
mous
databas
mascot
result
file
pool
scaffold
analysi
ident
describ
number
protein
match
revers
databas
follow
tabl
l
ex
sampl
g
sampl
g
ex
sampl
tabl
match
cfp
exosom
sampl
number
equal
number
fals
posit
fp
equat
fdr
fp
tp
number
total
posit
found
data
set
l
ex
g
g
ex
cfp
therefor
fdr
data
set
l
ex
g
g
ex
cfp
respect
insolut
ingel
analys
sampl
compil
scaffold
version
proteom
softwar
portland
order
valid
msmsbase
peptid
protein
identif
scaffold
program
ad
anoth
level
stringenc
util
peptid
protein
prophet
statist
analysi
protein
peptid
disqualifi
threshold
protein
identifi
subject
manual
valid
final
confirm
fp
identifi
use
exosom
sampl
exposur
mtb
wherev
applic
data
analyz
use
microsoft
excel
softwar
program
group
comparison
perform
use
unpair
student
ttest
exosom
purifi
mtbinfect
cell
analyz
em
shown
characterist
spheric
cupshap
appear
expect
size
nm
data
shown
isol
exosom
also
analyz
confirm
presenc
host
protein
compon
known
present
exosom
support
inform
tabl
expect
observ
member
annexin
famili
atpas
subunit
integrin
b
previous
observ
exosom
releas
mycobacterialinfect
cell
could
activ
cell
vivo
determin
mycobacteri
protein
compon
present
exosom
could
serv
antigen
promot
tcell
respons
perform
proteom
analysi
exosom
releas
mtbinfect
cell
tryptic
digest
exosom
protein
perform
insolut
ingel
optim
ms
well
maxim
protein
identif
total
mycobacteri
protein
identifi
tabl
support
inform
tabl
group
number
wellknown
mtb
antigen
includ
antigen
b
c
presenc
particularli
interest
protein
part
subunit
vaccin
current
clinic
trial
presenc
number
wellknown
immunodomin
mtb
antigen
exosom
highlight
tabl
like
explain
previou
observ
exosom
bcginfect
cell
activ
cell
inject
intranas
mice
interestingli
exosom
could
stimul
tcell
respons
absenc
adjuv
indic
purifi
exosom
antigen
adjuv
properti
vast
major
mycobacteri
protein
identifi
exosom
knownpredict
secret
summar
tabl
protein
like
secret
via
seca
secretori
system
releas
newli
describ
type
vii
secret
system
present
mycobacteria
nevertheless
coupl
mycobacteri
protein
present
exosom
expect
secret
includ
succin
semialdehyd
dehydrogenas
enzym
involv
mtb
intermediari
metabol
suggest
either
altern
mechan
releas
protein
mycobacteri
lysi
occur
within
infect
macrophag
subsequ
transport
protein
mvb
exosom
confirm
result
obtain
proteom
analysi
exosom
probe
subset
protein
western
blot
found
exosom
releas
mtbinfect
cell
uninfect
cell
contain
groe
katg
kda
lipoproteinlpqh
antigen
complex
glna
soda
fig
expect
exosom
popul
contain
host
protein
lysosomalassoci
membran
except
identif
lpqh
soda
western
blot
analysi
consist
find
observ
shotgun
proteom
approach
tabl
due
complex
exosom
sampl
inclus
murin
protein
ms
analysi
like
lpqh
soda
peptid
either
less
suscept
ioniz
suppress
abund
host
peptid
benefit
lcmsm
analysi
abil
identifi
exosom
protein
without
need
addit
detect
reagent
ie
antibodi
well
discov
protein
predict
addit
previou
studi
indic
secret
mtb
complex
suggest
protein
might
also
exosom
although
observ
presenc
western
blot
found
exosom
releas
infect
cell
also
contain
lcmsm
fig
tabl
sinc
proteom
analysi
indic
major
mtb
protein
present
exosom
known
secret
hypothes
major
exosom
protein
result
releas
mycobacteria
mycobacteri
lysi
within
macrophag
begin
test
hypothesi
treat
macrophag
protein
activ
secret
mtb
ie
cfp
anticip
least
mycobacteri
protein
endocytos
traffick
mvb
exosom
hypothesi
support
previou
studi
macrophag
expos
toxoplasma
gondii
protein
antigen
produc
exosom
contain
subset
protein
observ
similar
find
exosom
isol
cfptreat
cell
cfpexosom
contain
mani
protein
observ
exosom
releas
mtbinfect
macrophag
includ
antigen
complex
groe
among
other
tabl
fact
six
uniqu
protein
found
cfpexosom
surpris
sinc
protein
found
exosom
mtbinfect
cell
experiment
shown
comput
predict
secret
tabl
summari
mycobacteri
protein
identifi
exosom
mtbinfect
cell
wherea
identifi
cfptreat
cell
support
inform
tabl
identifi
protein
ident
observ
mtbinfect
cell
fig
cell
also
infect
irradi
mtb
evalu
whether
macrophagemedi
degrad
mtb
result
signific
transport
mycobacteri
protein
mvb
releas
exosom
despit
sustain
level
exosom
releas
cell
compar
uninfect
mtbinfect
cell
exosom
essenti
absent
mycobacteri
protein
fig
may
due
limit
releas
protein
lipid
compon
irradi
mtb
follow
phagocytosi
previous
report
exosom
isol
mycobacterialinfect
macrophag
contain
pamp
proinflammatori
also
shown
exosom
isol
bcg
mtbinfect
macrophag
induc
bmdc
activ
matur
sinc
exosom
deriv
cfptreat
cell
contain
number
mycobacteri
compon
hypothes
may
also
stimul
macrophag
dc
activ
shown
fig
observ
tnfa
product
macrophag
dc
respect
follow
treatment
cfpexosom
evalu
antigen
potenti
cfpexosom
splenocyt
harvest
cfp
vaccin
mice
ex
vivo
stimul
exosom
cfptreat
ut
cell
shown
fig
exosom
cfptreat
cell
could
stimul
splenocyt
produc
tnfa
ifng
interestingli
similar
quantiti
cfpexosom
cfp
alon
use
cfpexosom
promot
robust
tnfa
respons
compar
ex
vivo
stimul
cfp
suggest
either
enrich
molecul
exosom
stimul
tnfa
product
splenic
cell
like
macrophag
effici
present
molecul
splenic
cell
promot
tnfa
product
similar
ifng
product
splenocyt
treat
ex
vivo
cfpexosom
compar
cfp
alon
also
suggest
either
exosom
contain
potent
mtb
cultur
filtrat
antigen
exosom
effici
transfer
limit
number
mtb
antigen
antigenpres
cell
present
antigenspecif
cell
base
presenc
promin
mtb
antigen
cfpexosom
previou
studi
exosom
bcginfect
macrophag
hypothes
exosom
cfptreat
cell
could
activ
cell
vivo
test
predict
mice
administ
intranas
exosom
uninfect
cfptreat
cell
adjuv
describ
section
wk
final
vaccin
lung
mln
spleen
harvest
singl
cell
suspens
stimul
ex
vivo
cfp
cell
analyz
prolifer
ifng
product
memori
phenotyp
shown
fig
cell
isol
mice
treat
cfpexosom
show
increas
product
ifng
upon
restimul
cfp
evid
three
organ
adjuv
signific
effect
number
cell
posit
ifng
suggest
exosom
contain
adjuv
antigen
properti
conclus
support
data
shown
fig
indic
exosom
cfptreat
cell
promot
dc
activ
cell
isol
mice
treat
cfpexosom
mice
treat
uninfect
exosom
also
show
increas
prolifer
stimul
ex
vivo
cfp
fig
e
previou
studi
indic
antigenspecif
effector
memori
cell
may
play
import
role
protect
mtb
bcgvaccin
individu
therefor
address
whether
effector
memori
cell
produc
mice
vaccin
cfpexosom
found
hi
low
cell
indic
effector
memori
cell
three
organ
fig
g
togeth
data
suggest
vaccin
mice
exosom
isol
cfptreat
cell
induc
profil
tcell
activ
often
associ
mtb
control
ie
ifng
product
effector
memori
cell
previou
studi
indic
exosom
isol
mtbinfect
macrophag
immun
modulatori
activ
exosom
activ
innat
acquir
immun
respons
suggest
presenc
multipl
mycobacteri
compon
howev
previou
report
antigen
complex
identifi
studi
ms
proteom
approach
taken
identifi
mycobacteri
protein
present
exosom
releas
mtbinfect
cell
surprisingli
high
number
mycobacteri
protein
ie
identifi
along
number
expect
host
protein
high
number
particular
protein
identifi
protein
known
secret
mtb
includ
fibronectin
attach
protein
shown
previous
releas
outsid
phagosom
recent
studi
identifi
two
major
mechan
protein
target
intralumin
vesicl
mvb
subsequ
releas
exosom
one
involv
ubiquitin
protein
recogn
escrt
endosom
sort
complex
requir
transport
machineri
subsequ
traffick
retent
protein
intralumin
vesicl
second
mechan
appear
involv
aggreg
membran
protein
form
microdomain
may
stabil
exosom
membran
domain
although
find
ubiquitin
motif
among
differ
mtb
exosom
protein
could
determin
analysi
whether
protein
aggreg
within
phagosom
subsequ
traffick
endocyt
network
mvb
addit
known
pathway
evid
indic
may
escrtindepend
transport
mechan
whether
mycobacteri
protein
use
altern
target
pathway
must
wait
process
better
defin
complic
lack
studi
address
mechan
phagosom
protein
traffick
mvb
may
differ
plasma
membran
endosom
protein
target
mvb
exosom
independ
mycobacteri
protein
compon
target
mvbsexosom
clear
occur
cours
mtb
infect
vitro
vivo
time
public
studi
defin
microbi
compon
present
exosom
follow
infect
intracellular
pathogen
studi
hivinfect
macrophag
dc
suggest
hiv
may
bud
cell
exosom
exosomelik
vesicl
studi
shown
hiv
gag
protein
express
cell
show
preferenti
target
mvb
releas
exosom
studi
raposo
colleagu
shown
prion
protein
normal
scrappi
conform
traffick
mvb
releas
exosom
prion
diseas
fatal
neurodegen
disord
infecti
form
involv
transmiss
prion
protein
scrappi
conform
suscept
host
possibl
exosom
may
promot
transfer
prion
protein
intrigu
one
previou
studi
shown
mycobacteri
protein
glycolipid
lipoprotein
etc
affect
host
immun
system
function
either
promot
effect
immun
respons
potenti
inhibit
aspect
respons
degre
exosom
promot
inhibit
immun
like
depend
mycobacteri
compon
present
exosom
given
time
proteom
analysi
exosom
releas
infect
macrophag
describ
studi
first
ventur
dissect
protein
composit
futur
studi
need
defin
exosom
composit
may
chang
time
particularli
cours
vivo
infect
correl
bacteri
burden
stage
infect
eventu
goal
better
understand
exosom
role
cours
mtb
infect
nevertheless
previou
studi
demonstr
exosom
isol
bovi
bcginfect
cell
could
activ
cell
suggest
condit
exosom
infect
macrophag
promot
acquir
immun
respons
also
suggest
exosom
right
subset
mtb
compon
may
function
viabl
vaccin
candid
presenc
highli
antigen
mtb
protein
isol
exosom
support
possibl
member
complex
protein
found
exosom
origin
describ
promin
tb
antigen
anim
model
within
infect
human
subsequ
subunit
vaccin
studi
nonhuman
primat
show
antigen
along
anoth
wellknown
antigen
provid
protect
mtb
infect
clinic
trial
present
ongo
use
fusion
protein
subunit
vaccin
sinc
found
number
mtb
secret
protein
exosom
releas
mtbinfect
macrophag
test
whether
incub
macrophag
cfp
exogen
would
produc
exosom
contain
least
subset
protein
interestingli
found
mtb
protein
exosom
approxim
mtb
protein
cultur
supernat
find
includ
complex
traffick
mvb
exosom
suggest
effici
transport
mechan
howev
specif
mtb
protein
target
known
anoth
interest
observ
major
exosom
protein
also
present
exosom
mtbinfect
macrophag
indic
protein
target
mvb
exosom
independ
whether
traffic
phagosom
endocyt
pathway
import
note
mtb
wash
prior
macrophag
infect
cultur
supernat
ad
cell
time
infect
feed
protein
dc
b
cell
macrophag
produc
exosom
contain
ad
protein
perform
context
tumor
antigen
well
microbi
antigen
gondii
diphtheria
toxin
streptococcu
pneumonia
spike
protein
sarsassoci
coronaviru
suggest
may
mechan
engin
exosom
contain
specif
protein
howev
method
reach
full
potenti
need
better
understand
protein
traffick
mvb
exosom
hypothes
sinc
exosom
deriv
cfptreat
cell
contain
known
mtb
antigen
could
function
promot
activ
cell
vivo
data
support
hypothesi
number
cell
produc
ifng
upon
exvivo
stimul
compar
previou
studi
exosom
bcginfect
macrophag
use
vaccin
held
true
product
effect
memori
cell
similar
level
tcell
activ
induc
exosom
cfptreat
bcginfect
macrophag
suggest
mous
model
share
major
antigen
induc
acquir
immun
respons
howev
share
mtb
protein
major
contributor
tcell
respons
present
unknown
nevertheless
exosom
deriv
cfptreat
macrophag
distinct
advantag
gener
mtbinfect
macrophag
major
advantag
stem
remov
pathogen
infect
exosomegener
process
moreov
like
exosom
mtbinfect
macrophag
cfpexosom
requir
adjuv
activ
cell
vivo
could
promot
dc
activ
matur
vitro
contrast
cfp
alon
although
capabl
induc
tcell
activ
inject
mice
could
presenc
adjuv
import
consider
sinc
alum
approv
adjuv
use
human
futur
studi
determin
whether
cfpexosom
use
vaccin
mice
protect
mtb
infect
work
support
grant
j
nation
institut
allergi
infecti
diseas
antibodi
variou
mycobacteri
protein
well
mtb
cultur
filtrat
protein
gener
provid
colorado
state
univers
part
nih
niaid
contract
entitl
tuberculosi
vaccin
test
research
materi
author
declar
conflict
interest
